Bravatek Solutions (BVTK) 10-Q/A 26 Feb 15 2015 Q3 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Dec. 31, 2014	Feb. 24, 2015
Document and Entity Information
Entity Registrant Name	eCrypt Technologies, Inc.
Document Type	10-Q
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Entity Central Index Key	1449574
Current Fiscal Year End Date	-28
Entity Common Stock, Shares Outstanding		137,674,899
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2014	Mar. 31, 2014
CURRENT ASSETS
Cash	$58,468	$15,504
TOTAL CURRENT ASSETS	58,468	15,504
Property and equipment, net	8,703	7,826
TOTAL ASSETS	67,171	23,330
CURRENT LIABILITIES
Accounts Payable and Accrued Liabilities	136,948	26,180
Accounts Payable - Related Party	13,200	13,200
Accrued Interest on Loan	60,286	85,816
Accrued interest on loan-related party	249,252	193,764
Notes Payable - Related Party	558,500	553,000
Notes Payable	430,788	659,854
Convertible notes payable (net of unamortized discount of $775,708)	35,285
Derivative liabilities	894,334
TOTAL CURRENT LIABILITIES	2,378,593	1,531,814
LONG TERM LIABILITIES
Notes Payable		100,000
Notes Payable-Related Party		5,500
Accrued Interest on Loan		8,913
Accrued Interest on loan-related party		417
TOTAL LONG TERM LIABILITIES		114,830
TOTAL LIABILITIES	2,378,593	1,646,644
STOCKHOLDERS' DEFICIT
Preferred stock (10,000,000 Shares Authorized; Par Value $.0001 5,000,000 and 5,000,000 shares issued and outstanding as at December 31, 2014 and March 31, 2014)	500	500
Common stock (500,000,000 Shares Authorized; No Par Value; 130,178,513 and 135,979,802 shares issued and outstanding as at December 31, 2014 and March 31, 2014)	1,471,162	1,029,161
Additional Paid-in Capital	6,429,500	6,429,500
Stock subscription receivable	-300,000
Stock Subscription Payable	62,031	8,812
Accumulated Deficit	-9,974,615	-9,091,287
TOTAL STOCKHOLDERS' DEFICIT	-2,311,422	-1,623,314
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$67,171	$23,330

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Mar. 31, 2014
Balance Sheets Parenthetical
Unamortized discount	$775,708
Stockholder Equity
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	5,000,000	5,000,000
Preferred Stock, Shares Outstanding	5,000,000	5,000,000
Common Stock, Par Value	$0	$0
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares Issued	130,178,513	135,979,802
Common Stock, Shares Outstanding	130,178,513	135,979,802

STATEMENT_OF_OPERATIONS_Unaudi

STATEMENT OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
REVENUES
Sales				$1,270
OPERATING EXPENSES
Amortization and Depreciation	935	1,023	2,804	3,076
Advertisement and Promotion	4,129	1,976	11,218	19,401
General and Administrative	41,891	38,350	75,645	246,411
Professional Fees	246,052	20,478	556,480	65,025
TOTAL OPERATING EXPENSES	293,007	61,827	646,147	333,913
OPERATING LOSS	-293,007	-61,827	-646,147	-332,643
OTHER INCOME (EXPENSES)
Interest Expense	-18,707	-17,907	-59,327	-44,788
Interest Expense - Related Party	-20,936	-17,444	-56,525	-51,242
Loss on derivative liabilities	-94,340		-94,340
Amortization of debt discount	-36,285		-36,285
Debt Forgiveness	9,297		9,297
TOTAL OTHER INCOME (EXPENSES)	-160,971	-35,351	-237,180	-96,030
NET LOSS	($453,978)	($97,178)	($883,327)	($428,673)
WEIGHTED AVERAGE SHARES OUTSTANDING BASIC	126,968,654	135,953,511	130,424,607	135,900,575
Loss Per Share Basic	$0	$0	($0.01)	$0

STATEMENTS_OF_CASH_FLOWS_Unaud

STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	($883,327)	($428,673)
Adjustments for non-cash items:
Amortization and Depreciation	2,804	3,076
Stock issued for compensation	347,350	15,000
Interest on Loans	60,781	44,783
Interest on Loans Related Party	55,071	51,248
Change in derivative value	94,340
Amortization of debt discount	36,285
Debt forgiveness	-9,297
Changes in Operating Assets and Liabilities:
Accounts payable and accrued liabilities	110,767	12,092
Accounts payable-related party		8,700
NET CASH USED IN OPERATING ACTIVITIES	-185,226	-293,774
CASH FLOWS FROM INVESTING ACTIVITIES
Computer equipment	-3,680
NET CASH USED IN INVESTING ACTIVITIES	-3,680
CASH FLOWS FROM FINANCING ACTIVITIES
Common stock issuance	146,870
Proceeds from loans	85,000	280,000
Proceeds from loan-related party		5,500
NET CASH PROVIDED BY FINANCING ACTIVITIES	231,870	285,500
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	42,964	-8,274
CASH AND CASH EQUIVALENTS
Cash and Cash Equivalents Beginning of year	15,504	10,863
Cash and Cash Equivalents End of year	58,468	2,589
Supplemental Disclosures Of Cash Flow Information:
Common Stock Issued to Satisfy Common Stock Payable	8,812	14,625
Notes payable and accrued interest settled by issuing convertible notes	-499,993
Convertible notes issued in settlement of notes payable	499,993
Conversion of note payable	$1,000

Nature_of_Operations

Nature of Operations	9 Months Ended
	Dec. 31, 2014
Nature Of Operations
Nature of Operations	Ecrypt Technologies Inc., a Colorado corporation (“the Company”), was incorporated on April 19, 2007. The Company’s business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services. Products include software, hardware and services, and span a diverse variety of industries including, but not limited to, email security, user authentication, robotics, and cyber breach protection.

Significant_Accounting_Policie

Significant Accounting Policies	9 Months Ended
	Dec. 31, 2014
Significant Accounting Policies
Significant Accounting Policies	Basis of Presentation
	The financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“US GAAP”).
	In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present fairly the financial position as of December 31, 2014, and the results of operations and cash flows presented herein have been included in the financial statements. The financial statements should be read in conjunction with the Form 10-K for the year ended March 31, 2014, filed with the SEC on July 14, 2014.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that impact the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.
	Uncertainty as a Going Concern
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered recurring losses from operations since inception (April 19, 2007) up to December 31, 2014 of $9,974,615 which raises substantial doubt about its ability to continue as a going concern.
	The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through a private placement and public offering of its common stock. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.
	Revenue Recognition
	Product revenue and miscellaneous income are recognized as earned.
	The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-599, Revenue Recognition, Overall, SEC Materials ("Section 605-10-599"). Section 605-10-599 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction. When a right of return exists, the Company defers revenues until the right of return expires. The Company recognizes revenue from services at the time the services are completed.
	Stock-Based Compensation
	The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective – Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non employees for goods or services. Under this transition method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
	Related Parties
	Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or common significant influence.
	Foreign Currency Translation
	The measurement currency of the Company is the U.S. dollar. Transactions in foreign currencies are translated at the exchange rate in effect at the transaction date. Monetary assets and liabilities denominated in other than the measurement currency are translated at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in earnings.
	Net Earnings (Loss) per Share
	Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Dec. 31, 2014
Recent Accounting Pronouncements
Recent Accounting Pronouncements	The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

Stockholders_Deficit

Stockholders' Deficit	9 Months Ended
	Dec. 31, 2014
Stockholders Deficit
Stockholders' Deficit	a) Authorized:
	500,000,000 Common shares with no par value; 130,178,513 Common shares issued and outstanding;
	10,000,000 Preferred shares with $0.0001 par value; 5,000,000 Preferred shares issued and outstanding:
	During the period ended December 31, 2014, the Company effected the following stock transactions:
	On October 16, 2014, the Company issued 1,185,338 shares of common stock for officer compensation for a value of $148,167. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.125 per share. The compensation agreement calls for a total of 9,482,704 shares to be issued during a 28 month period. As of December 31, 2014, a total of 2,370,676 were issued under this agreement.
	On October 18, 2014, the Company issued 18,750 shares of common stock for compensation for a value of $2,625. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.143 per share. The compensation agreement calls for a total of 75,000 shares to be issued during a twelve month period. As of December 31, 2014, a total of 75,000 have been issued under this agreement.
	On October 24, 2014, the Company issued 18,750 shares of common stock for compensation for a value of $2,250 out of stock payable. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.12 per share. The compensation agreement calls for a total of 75,000 shares to be issued during a twelve-month period. As of December 31, 2014, a total of 75,000 shares have been issued under this agreement.
	On November 27, 2014, the Company issued 37,500 shares of common stock for director compensation for a value of $7,125. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.189. The compensation agreement calls for a total of 150,000 shares to be issued during a twelve month period. These shares were recorded as stock payable as of December 31, 2014. As of December 31, 2014, a total of 112,500 shares have been issued under this agreement.
	On October 24, 2014, the Company issued 171,875 shares of common stock for compensation for a value of $20,625. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.121 per share. The compensation agreement calls for a total of 2,750,000 shares to be issued during a 21 month period. Pursuant to the Restricted Shares Agreement, the remaining shares will be issued as follows: 171,875 on the six, nine, twelve, fifteen, eighteen and twenty one month anniversaries of the grant date, respectively. As of December 31, 2014, a total of 343,750 shares have vested under this agreement.
	On December 25, 2014, the Company issued 171,875 shares of common stock for compensation for a value of $18,906. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.11 per share. The compensation agreement calls for a total of 2,750,000 shares to be issued during a 21 month period. Pursuant to the Restricted Shares Agreement, the remaining shares will be issued as follows: 171,875 on the six, nine, twelve, fifteen, eighteen and twenty one month anniversaries of the grant date, respectively. The 171,875 shares were recorded as stock payable as of December 31, 2014. As of December 31, 2014, a total of 343,750 shares have vested under this agreement.
	On December 30, 2014 the Company issued 14,910 shares of common stock for the conversion of $1,000 of a $250,000 convertible note payable. The discounted share price of $0.067067 is based on a conversion ratio of 67% of the lowest closing bid prices for 20 days prior to conversion. The fair market value of these shares was $1,506. As of December 31, 2014, the outstanding principal amount of the note was $249,000.
	During the quarter ended December 31, 2014, the Company entered into a private placement subscription agreement that offers a total of 890,000 units for a value of $89,000, or $0.10 per unit. Each unit consists of one (1) share of the Company’s common stock, and one-half (1/2) common stock purchase Warrant. One full warrant entitles the holder to purchase one (1) share of the Corporation’s common stock at a price of $0.15 per share at any time within a 12 month period from the date of closing. As of December 31, 2014, 360,000 of these shares were recorded as stock payable.
	During the three months ended December 31, 2014, the Company issued a total of 1,939,623 shares valued at $228,173.

Stock_Options

Stock Options	9 Months Ended
	Dec. 31, 2014
Stock Options
Stock Options	On February 16, 2012 the Company granted a non-qualified stock option to its newly appointed director, Thomas Trkla as compensation for his services. The director is entitled to purchase a total of three hundred thousand (300,000) shares of restricted common stock for a price equal to $0.30 per share (Exercise Price), exercisable over a ten-year period thereafter. The option shall be vested during the 12 month period. As to the total number of Shares with respect to which the Option is granted, the Option shall be exercisable as follows: (i) 25% of the Option in the aggregate may be exercised upon the mutual execution of this Agreement (ii) 50% of the Option in the aggregate may be exercised on or after the four month anniversary of the Grant Date; (iii) 75% of the Option in the aggregate may be exercised on or after the eight month anniversary of the Grant Date; and (iv) 100% of the Option in the aggregate may be exercised on or after the twelve month anniversary of the Grant Date (the twelve month period commencing on the Grant Date and ending on the twelve month anniversary of the Grant Date being referred to as the “Vesting Period”). As of December 31, 2014, the director has not exercised any rights. The total fair value of these options at the date of grant was estimated to be $180,000 and was determined using the Black-Scholes option pricing model with an expected life of 10 years, a risk free interest rate of 1.99%, a dividend yield of 0% and expected volatility of 419%. Out of this $180,000 was recorded as stock based compensation expense through December 31, 2014 based on three hundred thousand (300,000) options vested.
		Number of Options		Weighted-Average Exercise Price per share		Weighted- Average Remaining Life (Years)
	Outstanding at as at 12/31/2013		300,000	$	0.3		8.88
	Granted		-	$	-		-
	Exercised		-	$	NA		NA
	Cancelled		-	$	NA		NA
	Outstanding as at 12/31/2014		300,000	$	0.3		7.88
	Exercisable at 12/31/2014		300,000	$	0.3		-

LoanRelated_Party

Loan-Related Party	9 Months Ended
	Dec. 31, 2014
Loan-Related Party
Loan-Related Party	As of December 31, 2014 and March 31, 2014, the balance of loans due to a related party was $558,500 and $553,000, respectively.
	The Company issued on May 18, 2010 a $215,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on April 29, 2011 a $15,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on May 9, 2011 a $36,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on June 24, 2011 a $100,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on July 7, 2011 a $40,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on August 5, 2011 a $24,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on September 2, 2011 a $20,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on September 30, 2011 a $20,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on October 19, 2011 a $25,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on December 6, 2011 a $20,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on January 11, 2012 a $38,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	The Company issued on June 27, 2013 a $5,500 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and will mature on June 27, 2015.
	Interest expense for the three months ended December 31, 2014, and 2013, was $20,936 and $17,444, respectively. Interest expense for the nine months ended December 31, 2014, and 2013, was $56,525 and $51,242, respectively.

Note_Payable

Note Payable	9 Months Ended
	Dec. 31, 2014
Note Payable
Notes Payable	As of December 31, 2014 and March 31, 2014, the balance of loans due to third parties was $430,788 and $659,854, respectively. During the quarter ended December 31, 2014 the loan balance was reduced by the issuance of convertible debt of $500,000 and the forgiveness of debt and interest payable of $18,594.
	The Company issued on December 18, 2012 a $49,980 unsecured note payable to a third party. The note bears interest at 10%, compounded annually and matured on December 18, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.
	Interest expense for the three months ended December 31, 2014, and 2013, was $18,707 and $17,907, respectively. Interest expense for the nine months ended December 31, 2014, and 2013, was $59,327 and $44,788, respectively.

Convertible_Debt_and_Derivativ

Convertible Debt and Derivative liabilities	9 Months Ended
	Dec. 31, 2014
Convertible Debt And Derivative Liabilities
Convertible Debt and Derivative liabilities	On December 21, 2014, the Company entered into a securities purchase agreement providing for the purchase of two convertible promissory notes in the aggregate principal amount of $156,000 each. One of the notes was funded on January 7, 2015, with the Company receiving $130,704 of net proceeds after payment of legal and origination expenses and a finders’ fee. The note bears interest at the rate of 8% per annum, is due and payable on December 19, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to 68% of the lowest closing bid price on the OTCQB during the 20 prior trading days. The second note, which has not been funded, has the same interest and conversion terms as the first note, but may be offset by a secured promissory note issued to the Company for $150,000, due on August 19, 2015, and accruing interest at the rate of 8% per annum.
	On December 24, 2014, the Company entered into a securities purchase agreement providing for the purchase of two convertible promissory notes in the aggregate principal amount of $156,000 each. One of the notes was funded on January 14, 2015, with the Company receiving $130,704 of net proceeds after payment of legal and origination expenses and a finders’ fee. The note bears interest at the rate of 8% per annum, is due and payable on December 19, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to 68% of the lowest closing bid price on the OTCQB during the 20 prior trading days. The second note, which has not been funded, has the same interest and conversion terms as the first note, but may be offset by a secured promissory note issued by union capital to the Company for $150,000, due on August 19, 2015, and accruing interest at the rate of 8% per annum.
	The combined amount of the unfunded notes is $300,000. Due to their variable conversion the Company accounted for these Notes under ASC Topic 815-15 “Embedded Derivative.” The derivative component of the obligation are initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts have being amortized to interest expense over the respective term of the related note. In determining the indicated value of the convertible note issued, the Company used the Black Scholes Option Model with a risk-free interest rate of .025%, volatility 204.17%, trading prices of $.10 per share and a conversion price $.07 per share.
	The balance of the convertible note at December 31, 2014 net of the discount and net of the receivable amounted to $0.
	A recap of the balance of outstanding convertible debt at December 31, 2014 is as follows:
	Principal balance	$	300,000
	Receivable-reflected in equity		(300,000
	Balance maturing for the period ending:
	31-Dec-14	$	0
	The Company has extinguished debt totaling $499,994 through the issuances of three 8% convertible promissory notes. The outstanding balances of these notes are convertible into a variable number of the Company’s common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. Therefore the Company accounted for these Notes under ASC Topic 815-15 “Embedded Derivative.” The derivative component of the obligation are initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts have being amortized to interest expense over the respective term of the related note. In determining the indicated value of the convertible note issued, the Company used the Black Scholes Option Model with a risk-free interest rate of .025%, volatility 204.17%, trading prices of $.10 per share and a conversion price $.07 per share.
	Amortization of the discounts for the nine months ended December 31, 2014 totaled $36,285, which was charged to interest expense.
	The Company valued the derivative liabilities at December 31, 2014 at $894,333. The Company recognized a change in the fair value of derivative liabilities for the three months ended December 31, 2014 of $249,424, which was charged to operations. The Company used the Black Scholes Option Model with a risk-free interest rate of .025%, volatility 204.17%, trading prices of $.10 per share and a conversion price $.07 per share.

Deferred_Revenue_Commitments_a

Deferred Revenue, Commitments, and Contingencies	9 Months Ended
	Dec. 31, 2014
Deferred Revenue Commitments And Contingencies
Deferred Revenue, Commitments, and Contingencies	On November 4, 2014 the Company entered into a 5 year agreement to provide a third party client “Ecrypt One” secure email services and website hosting services. The agreement calls for the payment of a one-time fee of $25,000, and an annually recurring fee of $5,015. The invoicing terms specify a pre-payment of $7,500 at the placement of order, a payment of $15,000 upon delivery of the product, and $2,500 at customer sign-off. As of December 31, 2014 the $7,500 pre-payment was due but has not been received and therefore was recorded as both deferred revenue and accounts receivable.

Subsequent_Events

Subsequent Events	9 Months Ended
	Dec. 31, 2014
Subsequent Events
Subsequent Events	During the month of January 2015 the company issued four convertible notes payable, two notes with a total face value of $312,000 and two notes with a total face value of $104,000 and stated interest of 8%. The outstanding balances of these notes are convertible into a variable number of the Company’s common stock. Based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion, the Company accounted for these Notes under ASC Topic 815-15 “Embedded Derivative.” The derivative component of the obligation are initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts will be amortized to interest expense over the respective term of the related note.
	On December 24, 2014, the Company issued a replacement convertible note payable, with a face value of $128,069.74 and stated interest of 8% to a third party investor, who had jut purchased $128,069.74 of debt from one of the Company’s other third party creditors. The outstanding balance of this note is convertible into a variable number of the Company’s common stock, based on a conversion ratio of 67% of the lowest closing bid prices for 20 days prior to conversion. From January 5, 2015 through February 19, 2015, the investor converted a total of $109,235.91 of the face value into 4,120,930 shares of common stock as itemized in the table below. As of February 23, 2015 the outstanding face value of the note was $18,833.83.
	Conversion Date	Converted Principal Amount		Discounted Conversion Price		Number of Common Shares Issued		Closing Stock Price		Fair Market Value of Shares		Outstanding Face Value
	5-Jan-15	$	5,000.00		0.051054		97,936	$	0.077	$	7,541.07	$	123,069.74
	6-Jan-15	$	4,600.00		0.051054		90,101	$	0.086	$	7,748.69	$	118,469.74
	7-Jan-15	$	7,200.00		0.051054		141,027	$	0.081	$	11,423.19	$	111,269.74
	8-Jan-15	$	4,300.00		0.051054		84,225	$	0.08	$	6,738.00	$	106,969.74
	9-Jan-15	$	3,400.00		0.051054		66,596	$	0.082	$	5,460.87	$	103,569.74
	12-Jan-15	$	2,000.00		0.05025		39,801	$	0.08	$	3,184.08	$	101,569.74
	14-Jan-15	$	2,300.00		0.0469		49,041	$	0.075	$	3,678.08	$	99,269.74
	15-Jan-15	$	2,100.00		0.0469		44,776	$	0.0725	$	3,246.26	$	97,169.74
	21-Jan-15	$	9,200.00		0.03015		305,141	$	0.0455	$	13,883.92	$	87,969.74
	22-Jan-15	$	11,000.00		0.02211		497,512	$	0.0342	$	17,014.91	$	76,969.74
	26-Jan-15	$	8,486.80		0.02211		383,844	$	0.0485	$	18,616.43	$	68,482.94
	28-Jan-15	$	8,500.00		0.02211		384,441	$	0.045	$	17,299.85	$	59,982.94
	29-Jan-15	$	3,400.00		0.02211		153,777	$	0.0475	$	7,304.41	$	56,582.94
	30-Jan-15	$	1,000.00		0.02211		45,228	$	0.053	$	2,397.08	$	55,582.94
	2-Feb-15	$	1,800.00		0.02211		81,411	$	0.0455	$	3,704.20	$	53,782.94
	3-Feb-15	$	4,800.00		0.02211		217,096	$	0.045	$	9,769.32	$	48,982.94
	4-Feb-15	$	5,000.00		0.02211		226,142	$	0.043	$	9,724.11	$	43,982.94
	5-Feb-15	$	8,000.00		0.02211		361,827	$	0.042	$	15,196.73	$	35,982.94
	9-Feb-15	$	4,700.00		0.02077		226,288	$	0.031	$	7,014.93	$	31,282.94
	10-Feb-15	$	3,300.00		0.02077		158,883	$	0.036	$	5,719.79	$	27,982.94
	12-Feb-15	$	1,049.11		0.02077		50,511	$	0.037	$	1,868.91	$	26,933.83
	17-Feb-15	$	2,100.00		0.02077		101,107	$	0.0315	$	3,184.87	$	24,833.83
	18-Feb-15	$	1,900.00		0.019095		99,502	$	0.031	$	3,084.56	$	22,933.83
	19-Feb-15	$	4,100.00		0.019095		214,716	$	0.033	$	7,085.63	$	18,833.83
	On December 12, 2014, the Company issued a replacement convertible note payable, with a face value of $250,000 and stated interest of 8% to a third party investor, who had just purchased $250,000 of debt from one of the Company’s other third party creditors. The outstanding balance of this note is convertible into a variable number of the Company’s common stock, based on a conversion ratio of 67% of the lowest closing bid prices for 20 days prior to conversion. From January 5, 2015 through February 19, 2015, the investor converted a total $78,720 of the face value and $445.70 of accrued interest into 2,843,580 shares of common stock as itemized in the table below. As of February 23, 2015 the outstanding face value of the note was $170,280.
	Conversion Date	Converted Principal Amount		Converted Interest		Discounted Conversion Price		Number of Common Shares Issued		Closing Stock Price		Fair Market Value of Shares		Outstanding Face Value
	5-Jan-15	$	5,390.00	$	7.09	$	0.051054		105,713	$	0.077	$	8,139.90	$	243,610.00
	6-Jan-15	$	3,370.00	$	5.17	$	0.051054		66,110	$	0.086	$	5,685.46	$	240,240.00
	7-Jan-15	$	3,055.00	$	5.36	$	0.051054		59,944	$	0.081	$	4,855.46	$	237,185.00
	8-Jan-15	$	3,225.00	$	6.36	$	0.051054		63,293	$	0.08	$	5,063.44	$	233,960.00
	9-Jan-15	$	1,925.00	$	4.22	$	0.051054		37,788	$	0.082	$	3,098.62	$	232,035.00
	12-Jan-15	$	2,405.00	$	6.85	$	0.05025		47,997	$	0.08	$	3,839.76	$	229,630.00
	13-Jan-15	$	1,055.00	$	3.24	$	0.05025		21,060	$	0.0755	$	1,590.03	$	228,575.00
	14-Jan-15	$	3,140.00	$	10.32	$	0.0469		67,171	$	0.075	$	5,037.83	$	225,435.00
	15-Jan-15	$	1,545.00	$	5.42	$	0.0469		33,058	$	0.0725	$	2,396.71	$	223,890.00
	16-Jan-15	$	175	$	0.65	$	0.0469		3,745	$	0.0701	$	262.52	$	223,715.00
	20-Jan-15	$	3,725.00	$	17.15	$	0.041942		89,222	$	0.0639	$	5,701.29	$	219,990.00
	21-Jan-15	$	6,605.00	$	31.85	$	0.03015		220,128	$	0.0455	$	10,015.82	$	213,385.00
	22-Jan-15	$	1,100.00	$	5.55	$	0.02211		50,002	$	0.0342	$	1,710.07	$	212,285.00
	23-Jan-15	$	2,050.00	$	10.78	$	0.02211		93,206	$	0.0342	$	4,194.27	$	210,235.00
	26-Jan-15	$	4,065.00	$	24.06	$	0.02211		184,942	$	0.0485	$	8,969.69	$	206,170.00
	27-Jan-15	$	3,300.00	$	20.25	$	0.02211		150,170	$	0.065	$	9,761.05	$	202,870.00
	28-Jan-15	$	1,415.00	$	8.99	$	0.02211		64,405	$	0.045	$	2,898.23	$	201,455.00
	29-Jan-15	$	2,450.00	$	16.11	$	0.02211		111,538	$	0.0475	$	5,298.06	$	199,005.00
	30-Jan-15	$	1,760.00	$	11.96	$	0.02211		80,143	$	0.053	$	4,247.58	$	197,245.00
	2-Feb-15	$	1,475.00	$	10.99	$	0.02211		67,209	$	0.0455	$	3,058.01	$	195,770.00
	3-Feb-15	$	2,085.00	$	15.99	$	0.02211		95,024	$	0.045	$	4,276.08	$	193,685.00
	4-Feb-15	$	1,400.00	$	11.05	$	0.02211		63,820	$	0.043	$	2,744.26	$	192,285.00
	5-Feb-15	$	2,140.00	$	17.35	$	0.02211		97,573	$	0.042	$	4,098.07	$	190,145.00
	6-Feb-15	$	2,615.00	$	21.78	$	0.02211		119,257	$	0.0418	$	4,984.94	$	187,530.00
	9-Feb-15	$	5,930.00	$	53.29	$	0.02077		288,074	$	0.031	$	8,930.29	$	181,600.00
	10-Feb-15	$	2,590.00	$	23.84	$	0.02077		125,847	$	0.036	$	4,530.49	$	179,010.00
	11-Feb-15	$	1,510.00	$	14.23	$	0.02077		73,386	$	0.033	$	2,421.74	$	177,500.00
	12-Feb-15	$	1,120.00	$	10.8	$	0.02077		54,444	$	0.037	$	2,014.43	$	176,380.00
	13-Feb-15	$	1,735.00	$	17.11	$	0.02077		84,358	$	0.037	$	3,121.25	$	174,645.00
	17-Feb-15	$	1,440.00	$	15.47	$	0.02077		70,076	$	0.0315	$	2,207.39	$	173,205.00
	18-Feb-15	$	1,245.00	$	13.64	$	0.019095		65,915	$	0.031	$	2,043.37	$	171,960.00
	19-Feb-15	$	1,680.00	$	18.78	$	0.019095		88,965	$	0.033	$	2,935.85	$	170,280.00
	On December 25, 2014, the Company issued 171,875 shares of common stock for compensation for a value of $18,906. The share price is valued at the adjusted closing price on the date of vesting of the shares which was $0.121 per share. The compensation agreement calls for a total of 2,750,000 shares to be issued during a 21 month period. Pursuant to the Restricted Shares Agreement, the remaining shares will be issued as follows: 171,875 on the six, nine, twelve, fifteen, eighteen and twenty one month anniversaries of the grant date, respectively. On January 6, 2015, the 171,875 shares were issued out of stock payable.
	During the quarter ended December 31, 2014, the Company entered into a private placement subscription agreement that offers a total of 890,000 units for a value of $89,000, or $0.10 per unit. Each unit consists of one (1) share of the Company’s common stock, and one-half (1/2) common stock purchase Warrant. One full warrant entitles the holder to purchase one (1) share of the Corporation’s common stock at a price of $0.15 per share at any time within a 12 month period from the date of closing. On January 7, 2015, the Company issued 360,000 shares of common stock out of stock payable.
	The note issued on January 15, 2015 has a face amount of $400,000 and stated interest rate of 12%. The outstanding balance of this note is convertible into a variable number of the Company’s common stock. Based on a conversion ratio of 60% of the lowest closing bid prices for 25 days prior to conversion or $.08 per share.
The note issued on January 16, 2015 has a face amount of $100,000 and stated interest rate of 12%. The outstanding balance of this note is convertible into a variable number of the Company’s common stock. Based on a conversion ratio of 45% of the lowest closing bid prices for 20 days prior to conversion or issue date.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $215,000 unsecured note payable issued on May 18, 2010 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $15,000 unsecured note payable issued on April 29, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $36,000 unsecured note payable issued on May 9, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $100,000 unsecured note payable issued on June 24, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $40,000 unsecured note payable issued on July 7, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $24,000 unsecured note payable issued on August 5, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $20,000 unsecured note payable issued on September 2, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $20,000 unsecured note payable issued on September 30, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $25,000 unsecured note payable issued on October 19, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $20,000 unsecured note payable issued on December 6, 2011 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $38,000 unsecured note payable issued on January 11, 2012 to a shareholder.
On February 16, 2015 the Company secured an extension through April 1, 2015 with no change in original terms of the agreement for a $49,980 unsecured note payable issued on December 18, 2012 to a third party.
On January 11, 2015, the Company entered into a securities purchase agreement providing for the purchase of two convertible promissory notes in the aggregate principal amount of $52,000 each. One of the notes was funded on January 13, 2015, with the Company receiving $47,500 of net proceeds after payment of legal and origination expenses. The note bears interest at the rate of 8% per annum, is due and payable on January 9, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to 67% of the lowest closing bid price on the OTCQB during the 15 prior trading days. The second note, which has not been funded, has the same interest and conversion terms as the first note, but may be offset by a secured promissory note issued to the Company for $50,000, due on September 9, 2015, and accruing interest at the rate of 8% per annum.
On January 19, 2015, the Company issued a convertible promissory note in the face amount of $100,000, which bears interest at the rate of 12% per annum, is due and payable on July 16, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to the lesser of (a) 55% of the lowest trading price during the 20 days preceding the execution of the note, or (b) 55% of the of the lowest traded price during the 20 trading days preceding conversion. The note was funded on January 28, 2015, with the Company receiving $93,000 of net proceeds after payment of legal and origination expenses.
On January 21, 2015, the Company issued a convertible promissory note in the face amount of $400,000, of which the Company is to assume $40,000 in original interest discount (“OID”), which together with any unpaid accrued interest is due two years after any funding of the note. The note is to be funded at the note holders discretion, and the initial tranche was funded on January 21, 2015, when the Company received cash in the amount of $50,000. The note is pre-payable for 90 days without interest, and incurs a one-time interest charge of 12% thereafter. The note balance funded (plus a pro rata portion of the OID together with any unpaid accrued interest) is convertible into shares of Company common stock at a conversion price equal to the lesser of $0.08 or 60% of the lowest traded price during the 25 prior trading days.
On February 3, 2015, the Company issued a collateralized secured convertible promissory for a 10% convertible promissory note with an aggregate principal amount of $252,500, of which the company is to assume an original issue discount of $22,500 (the “OID”) and legal fees and other expenses totaling $5,000, which together with any unpaid accrued interest is due on November 3, 2015. The note is to be issued in tranches with an initial tranche of $87,500, of which the company received $75,000 on February 6, 2015, with the remaining $5,000 being used for legal and other expenses and the Company assuming $7,500 of the OID. This convertible note together with any unpaid accrued interest is convertible into shares of Company common stock at a conversion price equal to the 60% of the average of the lowest three closing bid prices during the 20 prior trading days. The remaining three tranches, which have not yet been funded, of $55,000 under the note will consist of $50,000 in principal and $5,000 of the OID, and may be offset by three $50,000 promissory notes issued in favor of the Company, accruing interest at 8% per annum and maturing on November 3, 2015. In conjunction with the convertible note issued by the Company and the three promissory notes issued to the Company for the three additional tranches of funding to the Company, the Company issued four warrants for a total number of shares equal to $123,750 ($41,250 for the first warrant corresponding to funding on February 6, 2015, and $27,500 for the other three warrants corresponding to the future tranches of funding to the Company) divided by the conversion market price in the convertible note. The warrants have an exercise price of $0.10, subject to adjustment, and expire on January 3, 2020. Each of the warrants are only exercisable after the corresponding tranche of funding to the Company has been paid. Therefore, the first warrant is currently exercisable, but the other three warrants are not.
On February 10, 2015, the Company entered into an equity purchase agreement with a third party investor dated February 6, 2015, whereby the third party agreed to purchase up to $1,800,000 of the Company’s common stock, to be registered in a Form S-1 registration statement. The agreement will have a one-year term unless sooner terminated because $1,800,000 of the Company’s common stock has already been sold to the investor. During the term, the Company will have the right to deliver up to two put notices per month requiring it to purchase up to a maximum of $75,000 of shares for a specific amount. The purchase price for the shares covered by the put notice shall be equal to 75% of the lowest closing bid price for the ten trading days immediately preceding clearing of the estimated put shares (defined below). The Company will deliver to the investor, simultaneously with delivery of a put notice, a number of shares equal to 120% of the investment amount divided by the closing price of the Company’s common stock on the day preceding the put notice date. The actual number of shares purchased by the investor for the investment amount shall then be calculated by dividing the investment amount by the put purchase price. Any excess estimated put shares shall then be returned to the Company. The number of Shares sold to the investor at any time shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by the investor, would result in the investor owning more than 9.99% of all of the Company’s common stock then outstanding. Finally, as part of the equity purchase agreement, the investor is prohibited from executing any short sales of the Company’s common stock during the term of the equity purchase agreement.

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	9 Months Ended
	Dec. 31, 2014
Significant Accounting Policies Policies
Basis of Presentation	The financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“US GAAP”).
	In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present fairly the financial position as of December 31, 2014, and the results of operations and cash flows presented herein have been included in the financial statements. The financial statements should be read in conjunction with the Form 10-K for the year ended March 31, 2014, filed with the SEC on July 14, 2014.
Use of Estimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that impact the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.
Uncertainty as a Going Concern	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered recurring losses from operations since inception (April 19, 2007) up to December 31, 2014 of $9,974,615 which raises substantial doubt about its ability to continue as a going concern.
	The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through a private placement and public offering of its common stock. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.
Revenue Recognition	Product revenue and miscellaneous income are recognized as earned.
	The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-599, Revenue Recognition, Overall, SEC Materials ("Section 605-10-599"). Section 605-10-599 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction. When a right of return exists, the Company defers revenues until the right of return expires. The Company recognizes revenue from services at the time the services are completed.
Stock-Based Compensation	The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective – Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non employees for goods or services. Under this transition method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
Related Parties	Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or common significant influence.
Foreign Currency Translation	The measurement currency of the Company is the U.S. dollar. Transactions in foreign currencies are translated at the exchange rate in effect at the transaction date. Monetary assets and liabilities denominated in other than the measurement currency are translated at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in earnings.
Net Earnings (Loss) per Share	Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive.

Stock_options_Tables

Stock options (Tables)	9 Months Ended
	Dec. 31, 2014
Stock Options Tables
Summary of Stock options	The total fair value of these options at the date of grant was estimated to be $180,000 and was determined using the Black-Scholes option pricing model with an expected life of 10 years, a risk free interest rate of 1.99%, a dividend yield of 0% and expected volatility of 419%. Out of this $180,000 was recorded as stock based compensation expense through December 31, 2014 based on three hundred thousand (300,000) options vested.
		Number of Options		Weighted-Average Exercise Price per share		Weighted- Average Remaining Life (Years)
	Outstanding at as at 12/31/2013		300,000	$	0.3		8.88
	Granted		-	$	-		-
	Exercised		-	$	NA		NA
	Cancelled		-	$	NA		NA
	Outstanding as at 12/31/2014		300,000	$	0.3		7.88
	Exercisable at 12/31/2014		300,000	$	0.3		-

Convertible_Debt_and_Derivativ1

Convertible Debt and Derivative liabilities (Tables)	9 Months Ended
	Dec. 31, 2014
Convertible Debt And Derivative Liabilities Tables
Outstanding convertible debt	A recap of the balance of outstanding convertible debt at December 31, 2014 is as follows:
	Principal balance	$	300,000
	Receivable-reflected in equity		(300,000	)
	Balance maturing for the period ending:
	31-Dec-14	$	0

Subsequent_Events_Tables

Subsequent Events (Tables)	9 Months Ended
	Dec. 31, 2014
Subsequent Events Tables
Summary of issued a convertible note payable 1	Conversion Date	Converted Principal Amount		Discounted Conversion Price		Number of Common Shares Issued		Closing Stock Price		Fair Market Value of Shares		Outstanding Face Value
	5-Jan-15	$	5,000.00		0.051054		97,936	$	0.077	$	7,541.07	$	123,069.74
	6-Jan-15	$	4,600.00		0.051054		90,101	$	0.086	$	7,748.69	$	118,469.74
	7-Jan-15	$	7,200.00		0.051054		141,027	$	0.081	$	11,423.19	$	111,269.74
	8-Jan-15	$	4,300.00		0.051054		84,225	$	0.08	$	6,738.00	$	106,969.74
	9-Jan-15	$	3,400.00		0.051054		66,596	$	0.082	$	5,460.87	$	103,569.74
	12-Jan-15	$	2,000.00		0.05025		39,801	$	0.08	$	3,184.08	$	101,569.74
	14-Jan-15	$	2,300.00		0.0469		49,041	$	0.075	$	3,678.08	$	99,269.74
	15-Jan-15	$	2,100.00		0.0469		44,776	$	0.0725	$	3,246.26	$	97,169.74
	21-Jan-15	$	9,200.00		0.03015		305,141	$	0.0455	$	13,883.92	$	87,969.74
	22-Jan-15	$	11,000.00		0.02211		497,512	$	0.0342	$	17,014.91	$	76,969.74
	26-Jan-15	$	8,486.80		0.02211		383,844	$	0.0485	$	18,616.43	$	68,482.94
	28-Jan-15	$	8,500.00		0.02211		384,441	$	0.045	$	17,299.85	$	59,982.94
	29-Jan-15	$	3,400.00		0.02211		153,777	$	0.0475	$	7,304.41	$	56,582.94
	30-Jan-15	$	1,000.00		0.02211		45,228	$	0.053	$	2,397.08	$	55,582.94
	2-Feb-15	$	1,800.00		0.02211		81,411	$	0.0455	$	3,704.20	$	53,782.94
	3-Feb-15	$	4,800.00		0.02211		217,096	$	0.045	$	9,769.32	$	48,982.94
	4-Feb-15	$	5,000.00		0.02211		226,142	$	0.043	$	9,724.11	$	43,982.94
	5-Feb-15	$	8,000.00		0.02211		361,827	$	0.042	$	15,196.73	$	35,982.94
	9-Feb-15	$	4,700.00		0.02077		226,288	$	0.031	$	7,014.93	$	31,282.94
	10-Feb-15	$	3,300.00		0.02077		158,883	$	0.036	$	5,719.79	$	27,982.94
	12-Feb-15	$	1,049.11		0.02077		50,511	$	0.037	$	1,868.91	$	26,933.83
	17-Feb-15	$	2,100.00		0.02077		101,107	$	0.0315	$	3,184.87	$	24,833.83
	18-Feb-15	$	1,900.00		0.019095		99,502	$	0.031	$	3,084.56	$	22,933.83
	19-Feb-15	$	4,100.00		0.019095		214,716	$	0.033	$	7,085.63	$	18,833.83
Summary of issued a convertible note payable 2	Conversion Date	Converted Principal Amount		Converted Interest		Discounted Conversion Price		Number of Common Shares Issued		Closing Stock Price		Fair Market Value of Shares		Outstanding Face Value
	5-Jan-15	$	5,390.00	$	7.09	$	0.051054		105,713	$	0.077	$	8,139.90	$	243,610.00
	6-Jan-15	$	3,370.00	$	5.17	$	0.051054		66,110	$	0.086	$	5,685.46	$	240,240.00
	7-Jan-15	$	3,055.00	$	5.36	$	0.051054		59,944	$	0.081	$	4,855.46	$	237,185.00
	8-Jan-15	$	3,225.00	$	6.36	$	0.051054		63,293	$	0.08	$	5,063.44	$	233,960.00
	9-Jan-15	$	1,925.00	$	4.22	$	0.051054		37,788	$	0.082	$	3,098.62	$	232,035.00
	12-Jan-15	$	2,405.00	$	6.85	$	0.05025		47,997	$	0.08	$	3,839.76	$	229,630.00
	13-Jan-15	$	1,055.00	$	3.24	$	0.05025		21,060	$	0.0755	$	1,590.03	$	228,575.00
	14-Jan-15	$	3,140.00	$	10.32	$	0.0469		67,171	$	0.075	$	5,037.83	$	225,435.00
	15-Jan-15	$	1,545.00	$	5.42	$	0.0469		33,058	$	0.0725	$	2,396.71	$	223,890.00
	16-Jan-15	$	175	$	0.65	$	0.0469		3,745	$	0.0701	$	262.52	$	223,715.00
	20-Jan-15	$	3,725.00	$	17.15	$	0.041942		89,222	$	0.0639	$	5,701.29	$	219,990.00
	21-Jan-15	$	6,605.00	$	31.85	$	0.03015		220,128	$	0.0455	$	10,015.82	$	213,385.00
	22-Jan-15	$	1,100.00	$	5.55	$	0.02211		50,002	$	0.0342	$	1,710.07	$	212,285.00
	23-Jan-15	$	2,050.00	$	10.78	$	0.02211		93,206	$	0.0342	$	4,194.27	$	210,235.00
	26-Jan-15	$	4,065.00	$	24.06	$	0.02211		184,942	$	0.0485	$	8,969.69	$	206,170.00
	27-Jan-15	$	3,300.00	$	20.25	$	0.02211		150,170	$	0.065	$	9,761.05	$	202,870.00
	28-Jan-15	$	1,415.00	$	8.99	$	0.02211		64,405	$	0.045	$	2,898.23	$	201,455.00
	29-Jan-15	$	2,450.00	$	16.11	$	0.02211		111,538	$	0.0475	$	5,298.06	$	199,005.00
	30-Jan-15	$	1,760.00	$	11.96	$	0.02211		80,143	$	0.053	$	4,247.58	$	197,245.00
	2-Feb-15	$	1,475.00	$	10.99	$	0.02211		67,209	$	0.0455	$	3,058.01	$	195,770.00
	3-Feb-15	$	2,085.00	$	15.99	$	0.02211		95,024	$	0.045	$	4,276.08	$	193,685.00
	4-Feb-15	$	1,400.00	$	11.05	$	0.02211		63,820	$	0.043	$	2,744.26	$	192,285.00
	5-Feb-15	$	2,140.00	$	17.35	$	0.02211		97,573	$	0.042	$	4,098.07	$	190,145.00
	6-Feb-15	$	2,615.00	$	21.78	$	0.02211		119,257	$	0.0418	$	4,984.94	$	187,530.00
	9-Feb-15	$	5,930.00	$	53.29	$	0.02077		288,074	$	0.031	$	8,930.29	$	181,600.00
	10-Feb-15	$	2,590.00	$	23.84	$	0.02077		125,847	$	0.036	$	4,530.49	$	179,010.00
	11-Feb-15	$	1,510.00	$	14.23	$	0.02077		73,386	$	0.033	$	2,421.74	$	177,500.00
	12-Feb-15	$	1,120.00	$	10.8	$	0.02077		54,444	$	0.037	$	2,014.43	$	176,380.00
	13-Feb-15	$	1,735.00	$	17.11	$	0.02077		84,358	$	0.037	$	3,121.25	$	174,645.00
	17-Feb-15	$	1,440.00	$	15.47	$	0.02077		70,076	$	0.0315	$	2,207.39	$	173,205.00
	18-Feb-15	$	1,245.00	$	13.64	$	0.019095		65,915	$	0.031	$	2,043.37	$	171,960.00
	19-Feb-15	$	1,680.00	$	18.78	$	0.019095		88,965	$	0.033	$	2,935.85	$	170,280.00

Significant_Accounting_Policie2

Significant Accounting Policies (Details) (USD $)	92 Months Ended
	Dec. 31, 2014
Significant Accounting Policies Details
Losses from operations	$9,974,615

Stockholders_Deficit_Details_N

Stockholders' Deficit (Details Narartive) (USD $)	3 Months Ended	9 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Mar. 31, 2014
Stockholders Deficit Details Narartive
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	130,178,513	130,178,513	135,979,802
Common Stock, Shares Outstanding	130,178,513	130,178,513	135,979,802
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000
Preferred Stock, Par Value	$0.00	$0.00	$0.00
Preferred Stock, Shares Issued	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Outstanding	5,000,000	5,000,000	5,000,000
Shares recorded as stock payable	171,875	171,875
Outstanding principal amount of the note	$249,000	$249,000
Common Stock Value Issued for Compensation		176,823
Shares Issued	2,370,676	2,370,676
Shares Issued 1	75,000	75,000
Shares Issued 2	75,000	75,000
Shares Issued 3	112,500	112,500
Shares Issued 4	343,750	343,750
Total subscription agreement offers	890,000
Total subscription agreement offers, Amount	89,000
Total subscription agreement per unit	$0.10
Warrants recorded as stock payable	360,000	360,000
Company issued total shares	1,939,623
Company issued total shares, value	$228,173

Stock_Options_Details

Stock Options (Details) (USD $)	9 Months Ended
	Dec. 31, 2014
Number of options, outstanding
Outstanding, beginning of period (in shares)	300,000
Granted
Outstanding, end of period (in shares)	300,000
Exercisable, December 31, 2013	300,000
Options, weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$0.30
Granted
Exercised
Forfeited
Outstanding, end of period (in dollars per share)	$0.30
Exercisable, December 31, 2013	$0.30
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	8 years 10 months 17 days
Weighted Average Remaining Life (in years) Exercisable	7 years 10 months 17 days

Stock_Options_Details_Narrativ

Stock Options (Details Narrative) (USD $)	9 Months Ended
	Dec. 31, 2014
Stock Options Details Narrative
Stock Based Compensation Expense	$180,000
Options Vested	300,000

LoansRelated_Party_Details_Nar

Loans-Related Party (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
Loans-Related Party Details Narrative
Due to Related Parties	$558,500		$558,500		$553,000
Interest Expense - Related Party	$20,936	$17,444	$56,525	$51,242

Notes_Payable_Details_Narrativ

Notes Payable (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
Notes Payable Details Narrative
Loans due to third parties	$430,788		$430,788		$659,854
Issuance of convertible debt	500,000
Forgiveness of debt and interest payable	18,594		18,594
Interest expense	$18,707	$17,907	$59,327	$44,788

Convertible_Debt_and_Derivativ2

Convertible Debt and Derivative liabilities (Details) (USD $)	Dec. 31, 2014
Convertible Debt And Derivative Liabilities Details
Principal balance	$300,000
Receivable-reflected in equity	-300,000
Balance maturing for the period ending: 31-Dec-14	$0

Convertible_Debt_and_Derivativ3

Convertible Debt and Derivative liabilities (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Convertible Debt And Derivative Liabilities Details Narrative
Convertible note net of the discount			$0
Amortization of the discounts	36,285		36,285
Derivative liabilities	894,333		894,333
Change in the fair value of derivative liabilities	$249,424		$249,424

Deferred_Revenue_Commitments_a1

Deferred Revenue, Commitments, and Contingencies (Details Narrative) (USD $)	Dec. 31, 2014
Deferred Revenue Commitments And Contingencies Details Narrative
Pre-payment was due but not been received	$7,500